Biggest Busts in Dx Acquisitions
It's been the rare acquisition in in vitro diagnostics that has worked out to the acquirer's expectations. We chart for a number of different deals the prices acquirers paid and the prices they later sold their acquisitions for.
You may also be interested in...
EXACT-Tx will use funds from a NOK155m private placing to harness ultrasound in precision therapeutic targeting across a variety of indications and product classes.
More progress for partners’ amyloid-targeting antibody portfolio as they look to demonstrate benefit of early intervention in pre-symptomatic disease in new collaborative Phase III trial.
With the global pandemic leading to a big rise in mental health issues, medtech could have a role to play. The first of a two-part series on mental health focuses on transcranial magnetic stimulation systems. See what Neuronetics’ CEO Stephen Furlong said about it here.